Thermal Ablation in the Management for Colorectal Liver Metastases
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Metastasis".
Deadline for manuscript submissions: 20 March 2025 | Viewed by 7594
Special Issue Editors
Interests: interventional oncology; pancreatic ductal adenocarcinoma; irreversible electroporation; stereotactic ablative radiotherapy; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Targeted minimally invasive, image-guided therapies in the management of patients with colorectal liver metastases (CRLMs) play an increasingly important role in clinical oncology and health care in general. These rapidly evolving treatment modalities (e.g., microwave ablation, irreversible electroporation or stereotactic body radiation therapy) are characterized by the local delivery of (non-)thermal energy or radiation at a high dosage, directly affecting the tumor tissue in order to treat cancer more effectively. Their success is chiefly based on their minimally invasive nature, superior safety and toxicity profile, and often comparable or superior mid- and long-term oncologic outcomes, compared with conventional systemic therapy and surgical resection. The increasing role of minimally invasive, real-time, image-guided and/or navigated treatment techniques for CRLM is the primary topic of this Special Issue. We aim to procure high-quality original research and review articles that address the available kinds of (non-)thermal and radiation-related treatment options for CRLM in order to improve oncological outcomes in interventional and radiation oncology. Reports of studies highlighting the use of real-time image guiding or navigation tools or ablation confirmation techniques for volumetric assessment of the ablation zone are particularly welcome.
Prof. Dr. Martijn Meijerink
Dr. Robbert S. Puijk
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- image-guided therapies
- colorectal liver metastases (CRLMs)
- thermal ablation
- (non-)thermal and radiation-related treatment
- interventional and radiation oncology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: treatment of liver- and lungmetastases with Stereotactic Ablative Radiotherapy
Authors: Mark De Ridder
Affiliation: Department of Radiotherapy, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium